Your browser doesn't support javascript.
loading
In situ excitation of BODIPY fluorophores by 89Zr-generated Cerenkov luminescence.
Gristwood, Katie; Luli, Saimir; Rankin, Kenneth S; Knight, James C.
Afiliação
  • Gristwood K; School of Natural and Environmental Sciences, Faculty of Science, Agriculture and Engineering, Newcastle University, Newcastle Upon Tyne, NE1 7RU, UK. James.Knight2@newcastle.ac.uk.
  • Luli S; Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle, Newcastle Upon Tyne, NE2 4HH, UK. saimir.luli@newcastle.ac.uk.
  • Rankin KS; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK. kenneth.rankin@newcastle.ac.uk.
  • Knight JC; School of Natural and Environmental Sciences, Faculty of Science, Agriculture and Engineering, Newcastle University, Newcastle Upon Tyne, NE1 7RU, UK. James.Knight2@newcastle.ac.uk.
Chem Commun (Camb) ; 58(83): 11689-11692, 2022 Oct 18.
Article em En | MEDLINE | ID: mdl-36173358
Secondary Cerenkov-induced fluorescence imaging (SCIFI) is an emerging optical imaging technology that affords high signal-to-noise images by utilising radionuclide-generated Cerenkov luminescence to excite fluorescent probes. BODIPY dyes offer attractive properties for SCIFI, including high quantum yields and photochemical stability, yet their utility in this application in combination with clinically relevant ß+-emitting radioisotopes remains largely unexplored. In this report, the fluorescence properties of three meso-substituted BODIPY analogues have been assessed in combination with the positron emitter zirconium-89. Most notably, SCIFI data acquired over 7 days shows the BODIPY scaffold remain largely inert to radiolysis, indicating the promising utility of this fluorophore class in SCIFI applications.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article